Paltac Corporation (8283.T)
ValueMarkers Composite Index
36% below intrinsic value ($50)
Paltac Corporation (8283.T) — VMCI valuation read
Across 120 indicators, Paltac Corporation (8283.T) lands at VMCI 68/100. The Consumer Defensive sector median is 50, so the 18-point above-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.
No material Form 4 disclosures landed on 8283.T in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.
**Investor frame.** On Value, 8283.T trades at 17.0x earnings, 6% below the Consumer Defensive median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 13.0% sits 3.0pp above the Consumer Defensive median (10.0%). On Risk, net debt to EBITDA of 2.5x is the rate-sensitivity line to watch for 8283.T on the trailing balance sheet.
8283.T rose 0.2% over the trailing 7 days, with a +1.4% read on a 30-day basis.
Paltac Corporation engages in the wholesale of cosmetics, daily necessities, and over-the-counter drugs in Japan. The company was founded in 1898 and is headquartered in Osaka, Japan. Paltac Corporation is a subsidiary of MediPal Holdings Corporation.
Related Stocks in Consumer Defensive
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.